|
End-of-day quote
NSE India S.E.
21/09/2026
|
5-day change | 1st Jan Change | ||
| 1,508.10 INR | +0.58% |
|
+4.21% | +27.12% |
| 09-16 | Global Health Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| 08-01 | Global Health Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
| Market Cap | 405B 4.23B 3.69B 3.48B 3.17B 5.93B 5.94B 41.63B 16.04B 207B 15.9B 15.55B 667B | P/E 2027 * |
57x | P/E 2028 * | 45.6x |
|---|---|---|---|---|---|
| Enterprise Value | 401B 4.18B 3.65B 3.43B 3.13B 5.86B 5.87B 41.12B 15.85B 204B 15.71B 15.36B 658B | EV / Sales 2027 * |
7.54x | EV / Sales 2028 * | 6.56x |
| Free-Float |
33.61% | Yield 2027 * |
0.1% | Yield 2028 * | 0.13% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| MEDANTA | End-of-day quote | |
Bombay S.E.
| MEDANTA | Delayed |
Last Transcript: Global Health Limited
| 1 day | +0.58% | ||
| 1 week | +4.21% | ||
| Current month | +1.92% | ||
| 1 month | +6.98% | ||
| 3 months | +19.14% | ||
| 6 months | +49.96% | ||
| Current year | +27.12% |
| 1 week | 1,380.1 |  | 1,527 |
| 1 month | 1,380.1 | | 1,544 |
| Current year | 956 | | 1,544 |
| 1 year | 956 | | 1,544 |
| 3 years | 683.95 | | 1,544 |
| 5 years | 390.55 | | 1,544 |
| 10 years | 390.55 | | 1,544 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2017 | |
| Director of Finance/CFO | 29 | 08/02/2024 | |
Rajiv Sikka
CTO | Chief Tech/Sci/R&D Officer | - | 06/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 80 | 07/02/2014 | |
Sunil Sachdeva
BRD | Director/Board Member | 60 | 13/08/2004 |
| Director/Board Member | 71 | 06/10/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.58% | +4.21% | +11.36% | +121.71% | 4.2B | |
| +4.99% | +3.76% | +8.70% | +34.23% | 16.54B | |
| -0.07% | +2.23% | +15.11% | +78.53% | 13.4B | |
| -0.16% | -0.79% | -2.02% | +73.11% | 12.01B | |
| +0.87% | +0.62% | -35.02% | -54.08% | 11.12B | |
| +1.72% | +8.32% | - | - | 10.13B | |
| +0.32% | -0.26% | +6.20% | +86.70% | 10.05B | |
| 0.00% | 0.00% | -3.86% | -24.91% | 9.48B | |
| -0.18% | +3.64% | +67.48% | +6.10% | 9.07B | |
| 0.00% | +11.76% | -3.72% | - | 8.11B | |
| Average | +0.81% | +1.55% | +7.14% | +40.18% | 10.41B | |
| Weighted average by Cap. | +1.07% | +1.10% | +6.25% | +36.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 53.14B 555M 484M 455M 415M 778M 779M 5.45B 2.1B 27.07B 2.08B 2.04B 87.35B | 61.34B 640M 558M 526M 479M 898M 899M 6.3B 2.43B 31.25B 2.41B 2.35B 101B |
| Net income | 7.13B 74.42M 64.88M 61.11M 55.65M 104M 104M 732M 282M 3.63B 280M 273M 11.72B | 8.99B 93.86M 81.83M 77.07M 70.19M 132M 132M 923M 356M 4.58B 353M 345M 14.78B |
| Net Debt | -4.91B -51.26M -44.69M -42.09M -38.33M -71.87M -71.96M -504M -194M -2.5B -193M -188M -8.07B | -3.28B -34.25M -29.86M -28.13M -25.62M -48.03M -48.09M -337M -130M -1.67B -129M -126M -5.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | ₹1,508.10 | +0.58% | 321,886 |
| 18/09/26 | ₹1,499.40 | +5.29% | 703,445 |
| 17/09/26 | ₹1,424.00 | +1.38% | 152,324 |
| 16/09/26 | ₹1,404.60 | -0.95% | 227,556 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDANTA Stock
Select your edition
All financial news and data tailored to specific country editions
